User menu

Phase I study of seliciclib (CYC202 or R-roscovitine) in combination with gemcitabine (gem)/cisplatin (cis) in patients with advanced non-small cell lung cancer (NSCLC).

Bibliographic reference Siegel-Lakhai, WS ; Rodenstein, Daniel ; Beijnen, JH ; Gianella-Borradori, A ; Schellens, JHM ; et. al. Phase I study of seliciclib (CYC202 or R-roscovitine) in combination with gemcitabine (gem)/cisplatin (cis) in patients with advanced non-small cell lung cancer (NSCLC)..41st Annual Meeting of the American-Society-of-Clinical-Oncology (Orlando (Fl), May 13-17, 2005). In: Journal of Clinical Oncology, Vol. 23, no. 16, p. 150S-150S (2005)
Permanent URL http://hdl.handle.net/2078.1/60902